PHI with Atopic Dermatitis
How does this condition affect your private health insurance?
Atopic dermatitis (AD), also known as eczema, is a chronic inflammatory skin condition characterized by intense itching, dry skin, and recurrent red, scaly patches. Often starting in infancy or childhood, it can persist into adulthood. The disease involves a dysfunctional skin barrier, immune system dysregulation, and genetic factors, making skin susceptible to irritants and allergens. Persistent scratching can lead to skin thickening (lichenification), secondary bacterial or viral infections, and significant sleep disruption. AD commonly co-occurs with other atopic conditions like asthma and allergic rhinitis, forming part of the "atopic march." Management focuses on restoring the skin barrier, reducing inflammation, and alleviating symptoms through emollients, topical corticosteroids, and, in severe cases, systemic therapies.
PKV Risk Assessment
However, some specialized PHI providers may insure you with a surcharge of up to 30%.
Impact on Your Insurance Policy
Duration of Illness (Initial)
Several weeks (initial flare-up)
Duration of Illness (Lifetime)
Chronic disease with fluctuating severity, requiring lifelong management
Cost of Treatment (Initial)
Moderate (e.g., several hundred to a few thousand USD for initial diagnosis and topical treatments)
Cost of Treatment (Lifetime)
Significant (e.g., several thousand to tens of thousands USD over a lifetime, depending on severity and required therapies)
Mortality Rate
Extremely low (<0.1%), primarily from rare, severe secondary infections
Risk of Secondary Damages
High (e.g., 60-80% for skin infections, sleep disturbance, anxiety, depression, lichenification)
Probability of Full Recovery
Moderate (some children achieve remission by adulthood), but often a chronic condition requiring ongoing management
Underlying Disease Risk
High for other atopic conditions, such as asthma (20-50%), allergic rhinitis (30-50%), and food allergies (10-30%)